In a study with anti-EGFR CAR T cells labeled with zirconium-89 in GBM mice models, the cells' effective localization to tumor sites and persistence over a two-week period were demonstrated by PET imaging, which also linked their presence to better treatment results. This evidence concerns the gene EGFR and glioblastoma.